脉络膜新生血管的治疗现状与进展

The therapeutic situation and advancement in choroidal neovascularization

多种病因引起的脉络膜新生血管（CNV）是导致患者中心视力丧失的最常见原因之一。近年来对黄斑中心凹下CNV的治疗主要采用光动力疗法（PDT），最近也有针对新生血管形成和CNV病变炎性反应过程的药物应用于临床，未来的发展趋势可能是多种治疗机制的方法联合应用，以求获得最大疗效并减少治疗所产生的并发症。

Choroidal neovascularization （CNV） caused by multi-etiological factors is one of the most common reasons of visual loss. In recent studies, photodynamic therapy is the major treatment to sub-foveal CNV, and other anti-neovascular and anti-inflammatory agents were applied in clinical practice. In order to maximize the therapeutic effects and minimize the complications, combination management will be possibly applied by influencing multiple mechanisms.